MoensK, HigginsonIJ, HardingR: Are there differences in the prevalence of palliative care-related problems in people living with advanced cancer and either non-cancer conditions? A systematic review. J Pain Symptom Manage, 2014; 48:660–677.
2.
O'DonnellDE, BanzettRB, Carrieri-KohlmanV, et al.: Pathophysiology of dyspnea in chronic obstructive pulmonary disease: A roundtable. Proc Am Thorac Soc, 2007; 4:145–168.
3.
SilvaCS, NogueiraFR, PortoEF, et al.: Dynamic hyperinflation during activities of daily living in COPD patients. Chron Respir Dis, 2015; 12:189–196.
4.
SpathisA, BoothS, MoffatC, et al.: The breathing, thinking, functioning clinical model: A proposal to facilitate evidence-based breathlessness management in chronic respiratory disease. NPJ Prim Care Respir Med, 2017; 27:27.
5.
HigginsonIJ, BauseweinC, ReilyCC, et al.: An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: A randomized controlled trial. Lancet Respir Med, 2014; 2:979–987.
6.
BauseweinC, SchumacherP, BolzaniA: Integrated breathlessness services for people with chronic conditions. Curr Opin Support Palliat Care, 2018; 12:227–231.
7.
LenferinkA, Brusse-KeizerM, van der ValkPD, et al.Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 2017; 8:CD011682.
8.
McCarthyB, CaseyD, DevaneD, et al.: Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochran Database Syst Rev, 2015; 2:CD003793.
9.
BauseweinC, BoothS, GyselsM, HigginsonI: Non-pharmacologic interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Sys Rev, 2008; 2:CD005623.
10.
Cully. JA, Stanley MA, Deswal A, et al.: Cognitive-behavioral therapy for chronic cardiopulmonary conditions: Preliminary outcomes from an open trial. Prim Care Companion J Clin Psychiatry, 2010; 12:PCC.09m00896.
11.
BoveDG, MidtgaardJ, KaldanG, et al.Home-based COPD psychoeducation: A qualitative study of the patients' experiences. J Psychosom Res, 2017; 98:71–77.
12.
ValenzaMC, Valenza-PeñaG, Torres-SánchezI, et al.: Effectiveness of controlled breathing techniques on anxiety and depression in hospitalized patients with COPD: A randomized clinical trial. Respir Care, 2014; 59:209–215.
FengJ, WangX, LiX, et al.: Acupuncture for chronic obstructive pulmonary disease (COPD): A multicenter, randomized, sham-controlled trial. Medicine (Baltimore), 2016; 95:e4879.
16.
MinchomA, PunwaniR, FilshieJ, et al.: A randomized study comparing the effectiveness of acupuncture or morphine versus the combination for the relief of dyspnoea in patients with advanced non-small cell lung cancer and mesothelioma. Eur J Cancer, 2016; 61:102–110.
17.
SpoletiniG, AlotaibiM, BlasiF, HillNS: Heated humidified high-flow nasal oxygen in adults: Mechanisms of action and clinical implications. Chest, 2015; 148:253–261.
18.
KakoJ, MoritaT, TamahuchiT, et al.: Fan therapy is effective in relieving dyspnea in patients with terminally ill cancer: A parallel-arm, randomized controlled trial. J Pain Symptom Manage, 2018; 56:493–500.
19.
DavisMP, BehmB, BalachandranD: Looking both ways before crossing the street: Assessing the benefits and risk of opioids in treating patients at risk of sleep -disordered breathing for pain and dyspnea. J Opioid Manag, 2017; 13:183–196.
20.
BalesH, McDonaldJ, SmallwoodN, ManserR: Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochran Database Syst Rev, 2016; 3:CD011008.
21.
CurrowDC, McDonaldC, OatenS, et al.: Once-daily opioids for chronic dyspnea: A dose increment and pharmacovigilance study. J Pain Symptom Manage, 2011; 42:388–399.
22.
OxberrySG, TorgersonDJ, BlandJM, et al.: Short-term opioids for breathlessness in stable chronic heart failure: A randomized controlled trial. Eur J Heart Fail, 2011; 13:1006–1012.
23.
FerreiraDH, EckstromM, SajkovD, et al.: Extended-release morphine for chronic breathlessness in pulmonary arterial hypertension-A randomized, double-blind, placebo-controlled, crossover study. J Pain Symptom Manage, 2018; 56:483–492.
24.
EkstromMP, Bornefalk-HermanssonA, AbernethyAP, CurrowDC: Safety of benzodiazepines and opioids in very severe respiratory disease: National prospective study. BMJ, 2014; 348:g445.
25.
MarciniukD, GoodridgeD, HernandezP, et al.: Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: A Canadian Thoracic Society clinical practice guideline. Can Respir J, 2011; 18: 69–78.
26.
RockerGM, SimpsonAC, Joanne YoungBHSc, et al.: Opioid therapy for refractory dyspnea in patients with advanced chronic obstructive pulmonary disease: Patients' experiences and outcomes. CMAJ Open, 2013; 1: E27–E36.
27.
SimonST, HigginsonIJ, BoothS, et al.: Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochran Database Syst Rev, 2016; 10:CD007354.
28.
PeoplesAR, BushunowPW, GarlandSN, et al.: Buspirone for management of dyspnea in cancer patients receiving chemotherapy: A randomized placebo-controlled URC CCOP study. Support Care Cancer, 2016; 24:1339–1347.
29.
LovellN, BajwahS, MaddocksM, et al.: Use of mirtazapine in patients with chronic breathlessness: A case series. Palliat Med, 2018; 32:1518–1521.
